ArticleJCI insight2023
MIG6 loss confers resistance to ALK/ROS1 inhibitors in NSCLC through EGFR activation by low-dose EGF.
Nobuyuki Kondo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this papercites it
ArticleJCI insight2023
Nobuyuki Kondo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.